|
?:authorAffiliation
|
-
[\'Medical Oncology Division, Instituto do Cancer do Estado de São Paulo, Faculty of Medicine, Sao Paulo University, Sao Paulo, Brazil.\', \'Academic Trials Promoting Team, Jules Bordet Institute and Université Libre de Bruxelles, Brussels, Belgium.\', \'Instituto D\'Or de Pesquisa e Ensino, Rio de Janeiro, Brazil.\', \'Infectious Diseases Division, Instituto do Cancer do Estado de São Paulo, Faculty of Medicine, Sao Paulo University, Sao Paulo, Brazil.\', \'Faculty of Medicine, Sao Paulo University, Sao Paulo, Brazil.\', \'Emergency Department, Instituto do Cancer do Estado de São Paulo, Faculty of Medicine, Sao Paulo University, Sao Paulo, Brazil.\', \'Surgery Department, Instituto do Cancer do Estado de São Paulo, Faculty of Medicine, Sao Paulo University, Sao Paulo, Brazil.\', \'Service of Hematology, Transfusion and Cell Therapy, and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), ICESP and Hospital das Clinicas, Faculty of Medicine, Sao Paulo University, Sao Paulo, Brazil.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}